As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

While competitors like Eli Lilly and Novo Nordisk race to capture the booming weight-loss drug market, Novartis is steering ...

As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ramped up legal actions against its competitors. | As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ...

GOOGL), has announced two separate research collaborations with Eli Lilly (LLY) and Novartis (NVS). The deal with Eli Lilly (LLY) marks its first pharmaceutical partnership, the London-based ...

In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Schrodinger (SDGR – Research Report), with a ...

announcing its first pharma partnerships with Eli Lilly and Novartis, worth almost $3 billion. The company – led by Google DeepMind Founder Demis Hassabis and formed just over two years ago ...

and Eli Lilly’s Erbitux (cetuximab). It also covers Novartis’ Mekinist (trametinib) in melanoma as well as other BRAF ...

Recent health industry updates reveal Sun Pharma's profit surge due to specialty drugs, Pfizer's strategic focus under ...

Bearing that in mind, we used TipRanks’ Stock Comparison Tool to place Eli Lilly (LLY), Novartis (NVS), and Intuitive Surgical (ISRG) against each other to find the healthcare stock with a ...

Pfizer, Sanofi and others report Q3 beats; AbbVie, Roche and Novartis strike big deals; the 2024 presidential election looms; ...

A new guideline advises most patients to continue GLP-1 drugs before surgery. The FDA warns against California-made ...